nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—CYP3A4—bone cancer	0.815	1	CbGaD
Cisapride—Gefitinib—CHEK2—bone cancer	0.00779	0.572	CrCbGaD
Cisapride—CYP2B6—Cisplatin—bone cancer	0.00537	0.367	CbGbCtD
Cisapride—CYP2B6—Doxorubicin—bone cancer	0.0036	0.246	CbGbCtD
Cisapride—Gefitinib—EGFR—bone cancer	0.00311	0.229	CrCbGaD
Cisapride—CYP2C9—Cisplatin—bone cancer	0.00284	0.194	CbGbCtD
Cisapride—CYP2D6—Doxorubicin—bone cancer	0.00174	0.119	CbGbCtD
Cisapride—Iloperidone—CYP3A4—bone cancer	0.00158	0.116	CrCbGaD
Cisapride—Gefitinib—CYP3A4—bone cancer	0.00114	0.0835	CrCbGaD
Cisapride—CYP3A4—Doxorubicin—bone cancer	0.00111	0.0755	CbGbCtD
Cisapride—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000177	0.00113	CbGpPWpGaD
Cisapride—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000177	0.00113	CbGpPWpGaD
Cisapride—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.000175	0.00112	CbGpPWpGaD
Cisapride—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000174	0.00111	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—NDUFA12—bone cancer	0.000172	0.0011	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—BRAF—bone cancer	0.000171	0.00109	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—GRM4—bone cancer	0.00017	0.00108	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—RGS1—bone cancer	0.00017	0.00108	CbGpPWpGaD
Cisapride—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000165	0.00105	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—SMO—bone cancer	0.000163	0.00104	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—GRM1—bone cancer	0.000162	0.00104	CbGpPWpGaD
Cisapride—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.00016	0.00103	CbGpPWpGaD
Cisapride—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000159	0.00102	CbGpPWpGaD
Cisapride—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000158	0.00101	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000158	0.00101	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—SMO—bone cancer	0.000156	0.000998	CbGpPWpGaD
Cisapride—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000154	0.000982	CbGpPWpGaD
Cisapride—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000152	0.000969	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—GRM4—bone cancer	0.000151	0.000964	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—RGS1—bone cancer	0.000151	0.000964	CbGpPWpGaD
Cisapride—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000149	0.000951	CbGpPWpGaD
Cisapride—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.000148	0.000943	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—GRM1—bone cancer	0.000147	0.000941	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000146	0.000935	CbGpPWpGaD
Cisapride—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000146	0.00093	CbGpPWpGaD
Cisapride—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.000144	0.000922	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—SMO—bone cancer	0.000144	0.00092	CbGpPWpGaD
Cisapride—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000143	0.000917	CbGpPWpGaD
Cisapride—KCNH2—Neuronal System—MDM2—bone cancer	0.000143	0.000916	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—GNA11—bone cancer	0.000143	0.000912	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—NT5C3A—bone cancer	0.000143	0.000911	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—SMO—bone cancer	0.000142	0.000905	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—CDK4—bone cancer	0.000138	0.000885	CbGpPWpGaD
Cisapride—CYP2C19—Biological oxidations—GSTP1—bone cancer	0.000137	0.000877	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—GRM4—bone cancer	0.000137	0.000875	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—RGS1—bone cancer	0.000137	0.000875	CbGpPWpGaD
Cisapride—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	0.000135	0.000865	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—RGS1—bone cancer	0.000133	0.000851	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—GRM4—bone cancer	0.000133	0.000851	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—ATF1—bone cancer	0.000133	0.000848	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—RGS1—bone cancer	0.000131	0.000837	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—GRM4—bone cancer	0.000131	0.000837	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—GRM1—bone cancer	0.000131	0.000836	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—NT5C3A—bone cancer	0.000131	0.000835	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—IL3—bone cancer	0.000129	0.000827	CbGpPWpGaD
Cisapride—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000127	0.000814	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—NDUFA12—bone cancer	0.000127	0.000813	CbGpPWpGaD
Cisapride—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.000126	0.000806	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—GSTP1—bone cancer	0.000125	0.000799	CbGpPWpGaD
Cisapride—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.000125	0.000799	CbGpPWpGaD
Cisapride—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.000124	0.000795	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—NDUFA12—bone cancer	0.000124	0.000795	CbGpPWpGaD
Cisapride—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	0.000123	0.000788	CbGpPWpGaD
Cisapride—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.000123	0.000788	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—RGS1—bone cancer	0.000121	0.000772	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—GRM4—bone cancer	0.000121	0.000772	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—RGS1—bone cancer	0.000119	0.00076	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—GRM4—bone cancer	0.000119	0.00076	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—GRM1—bone cancer	0.000119	0.000759	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—GRM1—bone cancer	0.000115	0.000738	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—GRM1—bone cancer	0.000114	0.000726	CbGpPWpGaD
Cisapride—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000113	0.000721	CbGpPWpGaD
Cisapride—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000113	0.000721	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TGFBR2—bone cancer	0.000111	0.000707	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NDUFA12—bone cancer	0.000108	0.000688	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	0.000108	0.000687	CbGpPWpGaD
Cisapride—CYP1A2—Biological oxidations—GSTP1—bone cancer	0.000107	0.000683	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—NT5C3A—bone cancer	0.000105	0.000674	CbGpPWpGaD
Cisapride—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	0.000105	0.000674	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—GRM1—bone cancer	0.000105	0.00067	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—GNA11—bone cancer	0.000104	0.000668	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—IGF1R—bone cancer	0.000104	0.000666	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—SMO—bone cancer	0.000104	0.000663	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—GRM1—bone cancer	0.000103	0.000659	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—NT5C3A—bone cancer	0.000103	0.000659	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—RGS1—bone cancer	0.0001	0.000641	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—GRM4—bone cancer	0.0001	0.000641	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NDUFA12—bone cancer	9.62e-05	0.000614	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—GNA11—bone cancer	9.49e-05	0.000606	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—IL3—bone cancer	9.47e-05	0.000605	CbGpPWpGaD
Cisapride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	9.33e-05	0.000596	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NT5C3A—bone cancer	8.93e-05	0.00057	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—JUN—bone cancer	8.92e-05	0.00057	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NDUFA12—bone cancer	8.84e-05	0.000565	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NDUFA12—bone cancer	8.77e-05	0.00056	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—GRM1—bone cancer	8.7e-05	0.000556	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—IL3—bone cancer	8.6e-05	0.00055	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—GNA11—bone cancer	8.43e-05	0.000539	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—SMO—bone cancer	8.37e-05	0.000535	CbGpPWpGaD
Cisapride—CYP3A4—Biological oxidations—GSTP1—bone cancer	8.25e-05	0.000527	CbGpPWpGaD
Cisapride—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	8.14e-05	0.00052	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—RGS1—bone cancer	8.09e-05	0.000517	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GRM4—bone cancer	8.09e-05	0.000517	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NT5C3A—bone cancer	7.97e-05	0.000509	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—GNA11—bone cancer	7.65e-05	0.000489	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—IL3—bone cancer	7.64e-05	0.000488	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—KIT—bone cancer	7.55e-05	0.000483	CbGpPWpGaD
Cisapride—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	7.53e-05	0.000481	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NDUFA12—bone cancer	7.49e-05	0.000479	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—GNA11—bone cancer	7.44e-05	0.000475	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—SMO—bone cancer	7.38e-05	0.000472	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NT5C3A—bone cancer	7.33e-05	0.000468	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—GNA11—bone cancer	7.32e-05	0.000468	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—SMO—bone cancer	7.27e-05	0.000464	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NT5C3A—bone cancer	7.26e-05	0.000464	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GRM4—bone cancer	7.14e-05	0.000456	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—RGS1—bone cancer	7.14e-05	0.000456	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—BRAF—bone cancer	7.1e-05	0.000454	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GRM4—bone cancer	7.03e-05	0.000449	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—RGS1—bone cancer	7.03e-05	0.000449	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GRM1—bone cancer	7.02e-05	0.000448	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL3—bone cancer	6.94e-05	0.000443	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—EGFR—bone cancer	6.88e-05	0.00044	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—GNA11—bone cancer	6.75e-05	0.000432	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—IL3—bone cancer	6.74e-05	0.000431	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—GNA11—bone cancer	6.65e-05	0.000425	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—IL3—bone cancer	6.63e-05	0.000424	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	6.54e-05	0.000418	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—ENO2—bone cancer	6.25e-05	0.000399	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NT5C3A—bone cancer	6.21e-05	0.000397	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GRM1—bone cancer	6.19e-05	0.000396	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—SMO—bone cancer	6.13e-05	0.000392	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL3—bone cancer	6.12e-05	0.000391	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GRM1—bone cancer	6.09e-05	0.000389	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL3—bone cancer	6.02e-05	0.000385	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—MDM2—bone cancer	5.95e-05	0.00038	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—TP53—bone cancer	5.89e-05	0.000376	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—DHFR—bone cancer	5.79e-05	0.00037	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NDUFA12—bone cancer	5.78e-05	0.00037	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—ENO2—bone cancer	5.72e-05	0.000366	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—GNA11—bone cancer	5.6e-05	0.000358	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GNA11—bone cancer	5.41e-05	0.000346	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—DHFR—bone cancer	5.31e-05	0.000339	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ATF1—bone cancer	5.21e-05	0.000333	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—JUN—bone cancer	5.17e-05	0.00033	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL3—bone cancer	5.08e-05	0.000325	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—MMP9—bone cancer	5.03e-05	0.000322	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GNA11—bone cancer	4.96e-05	0.000317	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SMO—bone cancer	4.94e-05	0.000316	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CYP3A4—bone cancer	4.91e-05	0.000314	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NT5C3A—bone cancer	4.79e-05	0.000306	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ENO2—bone cancer	4.62e-05	0.000295	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GNA11—bone cancer	4.52e-05	0.000289	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ENO2—bone cancer	4.51e-05	0.000288	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CYP3A4—bone cancer	4.5e-05	0.000288	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SMO—bone cancer	4.36e-05	0.000279	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TGFBR2—bone cancer	4.34e-05	0.000278	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SMO—bone cancer	4.29e-05	0.000274	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—DHFR—bone cancer	4.28e-05	0.000274	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ATF1—bone cancer	4.2e-05	0.000269	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GSTP1—bone cancer	4.2e-05	0.000268	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—DHFR—bone cancer	4.19e-05	0.000268	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL3—bone cancer	4.1e-05	0.000262	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IGF1R—bone cancer	4.09e-05	0.000261	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—EGFR—bone cancer	4.07e-05	0.00026	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GNA11—bone cancer	4e-05	0.000256	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GNA11—bone cancer	3.99e-05	0.000255	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GNA11—bone cancer	3.93e-05	0.000251	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GNA11—bone cancer	3.91e-05	0.00025	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ENO2—bone cancer	3.91e-05	0.00025	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GSTP1—bone cancer	3.85e-05	0.000246	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ATF1—bone cancer	3.71e-05	0.000237	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ATF1—bone cancer	3.65e-05	0.000233	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CYP3A4—bone cancer	3.63e-05	0.000232	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—DHFR—bone cancer	3.63e-05	0.000232	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL3—bone cancer	3.62e-05	0.000231	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL3—bone cancer	3.56e-05	0.000227	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CYP3A4—bone cancer	3.55e-05	0.000227	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TGFBR2—bone cancer	3.51e-05	0.000224	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ENO2—bone cancer	3.49e-05	0.000223	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TP53—bone cancer	3.41e-05	0.000218	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GNA11—bone cancer	3.39e-05	0.000217	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IGF1R—bone cancer	3.3e-05	0.000211	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—DHFR—bone cancer	3.24e-05	0.000207	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ENO2—bone cancer	3.21e-05	0.000205	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ENO2—bone cancer	3.18e-05	0.000203	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GSTP1—bone cancer	3.1e-05	0.000198	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TGFBR2—bone cancer	3.09e-05	0.000198	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP3A4—bone cancer	3.07e-05	0.000196	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.06e-05	0.000195	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TGFBR2—bone cancer	3.04e-05	0.000195	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GSTP1—bone cancer	3.03e-05	0.000194	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GNA11—bone cancer	3.03e-05	0.000193	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—DHFR—bone cancer	2.98e-05	0.00019	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—KIT—bone cancer	2.96e-05	0.000189	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—DHFR—bone cancer	2.95e-05	0.000189	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1R—bone cancer	2.91e-05	0.000186	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1R—bone cancer	2.86e-05	0.000183	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—BRAF—bone cancer	2.79e-05	0.000178	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GNA11—bone cancer	2.78e-05	0.000178	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GNA11—bone cancer	2.76e-05	0.000176	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP3A4—bone cancer	2.74e-05	0.000175	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.73e-05	0.000174	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ENO2—bone cancer	2.72e-05	0.000174	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—EGFR—bone cancer	2.7e-05	0.000173	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSTP1—bone cancer	2.63e-05	0.000168	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP3A4—bone cancer	2.52e-05	0.000161	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—DHFR—bone cancer	2.52e-05	0.000161	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP3A4—bone cancer	2.5e-05	0.00016	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.49e-05	0.000159	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KIT—bone cancer	2.39e-05	0.000153	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GNA11—bone cancer	2.36e-05	0.000151	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTP1—bone cancer	2.35e-05	0.00015	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MDM2—bone cancer	2.33e-05	0.000149	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—BRAF—bone cancer	2.25e-05	0.000144	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—EGFR—bone cancer	2.18e-05	0.000139	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTGS2—bone cancer	2.18e-05	0.000139	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTP1—bone cancer	2.16e-05	0.000138	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTP1—bone cancer	2.14e-05	0.000137	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP3A4—bone cancer	2.14e-05	0.000137	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.13e-05	0.000136	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KIT—bone cancer	2.11e-05	0.000135	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ENO2—bone cancer	2.1e-05	0.000134	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KIT—bone cancer	2.08e-05	0.000133	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—JUN—bone cancer	2.03e-05	0.00013	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTGS2—bone cancer	1.99e-05	0.000127	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—BRAF—bone cancer	1.98e-05	0.000127	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MMP9—bone cancer	1.97e-05	0.000126	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—BRAF—bone cancer	1.95e-05	0.000125	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—DHFR—bone cancer	1.95e-05	0.000124	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—EGFR—bone cancer	1.92e-05	0.000123	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.89e-05	0.000121	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MDM2—bone cancer	1.88e-05	0.00012	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTP1—bone cancer	1.83e-05	0.000117	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GNA11—bone cancer	1.82e-05	0.000116	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MDM2—bone cancer	1.66e-05	0.000106	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—JUN—bone cancer	1.64e-05	0.000105	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MDM2—bone cancer	1.64e-05	0.000105	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—bone cancer	1.61e-05	0.000103	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EGFR—bone cancer	1.6e-05	0.000102	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MMP9—bone cancer	1.59e-05	0.000102	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—bone cancer	1.57e-05	0.0001	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—JUN—bone cancer	1.45e-05	9.23e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—JUN—bone cancer	1.42e-05	9.09e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTP1—bone cancer	1.41e-05	9.02e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MMP9—bone cancer	1.41e-05	8.98e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MMP9—bone cancer	1.38e-05	8.84e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—bone cancer	1.36e-05	8.7e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—bone cancer	1.34e-05	8.56e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EGFR—bone cancer	1.29e-05	8.23e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—bone cancer	1.22e-05	7.77e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EGFR—bone cancer	1.14e-05	7.26e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—bone cancer	1.12e-05	7.14e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EGFR—bone cancer	1.12e-05	7.14e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—bone cancer	1.11e-05	7.08e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—bone cancer	1.08e-05	6.91e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—bone cancer	9.54e-06	6.1e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—bone cancer	9.47e-06	6.05e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—bone cancer	9.39e-06	6e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—bone cancer	7.31e-06	4.67e-05	CbGpPWpGaD
